JPMorgan Chase’s SPOTLIGHT and 3 Dow 30 Stocks Making Waves

JPMorgan Chase & Co. (NYSE:JPM) deputy general counsel Gregory Baer detailed the firm’s “doomsday plan” at Harvard Law School in March, using a hypothetical loss of $50 billion. The presentation was unexpectedly candid, in that Baer admitted that the company could “absorb substantial losses without failing, there are limits to the capital buffers of even the healthiest banks”, according to The Financial Times.

Don’t Miss: Jamie Dimon: OOPS, We Didn’t Know What We Were Doing.

3M Co. (NYSE:MMM) presenters at the Deutsche Bank Global Industrials and Basic Materials Conference, expect the electronic sector to show weakness in the first half of this year, but might improve in the second half, despite slowness in the Asia Pacific region, driven by challenging environment in China.

Merck & Co. Inc. (NYSE:MRK) reports new data from two pivotal Phase III efficacy trials for suvorexant, the investigational drug Merck is developing for the treatment of insomnia. The evaluations show that suvorexant significantly decreased the time it took patients to fall asleep and increased the amount of time that patients stayed asleep, as soon as the first night and at the three-month time point when compared to placebo.

Microsoft Corporation’s (NASDAQ:MSFT) and Apple’s (NASDAQ:AAPL) operating systems which lead the market, are said in the Wall Street Journal‘s technology columnist Walt Mossberg’s review, to remain superior to Chrome OS, which is Google’s (NASDAQ:GOOG) redesigned PC operating system. The analyst, however, does comment that Chrome is ‘improved’.

Don’t Miss: Are These Super Companies GANGING UP on Intel?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.